Tournament: UK Season Opener | Round: 2 | Opponent: Durham RL | Judge: Saianurag Karavadi
Innovation’s declining – increasing complexity, mediocre research and patents, and balkanization from university patents
Gold 21, E Richard. E. Richard Gold is a CIGI senior fellow and a James McGill Professor with McGill University’s Faculty of Law and was the founding director of the Centre for Intellectual Property Policy. “The fall of the innovation empire and its possible rise through open science.” Research policy vol. 50,5 (2021): 104226. doi:10.1016/j.respol.2021.104226anop
While Milton (1966, 15) assumed that research productivity ---- further, steeper, decline in the efficiency of the innovation system.
Global IPR laws founded upon the TRIPS agreement exacerbate global inequality. You should reject neg args – they are probably based on unfounded assumptions
Ranjan 18 Rajiv Ranjan is an Assistant Professor, CMS Business School, Bangalore, Karnataka, India. “Politics of Intellectual Property Rights (IPRs)
in Medicine: The Dichotomies” https://journals.sagepub.com/doi/abs/10.1177/2319714518789762?journalCode=fiba aaditg
Introduction The health care --- protection would not benefit developing countries.
Pharma patent practices serve to keep drug prices high: evergreening, product hopping, patent thickets, pay for delay
Richards et al 20 Kevin T. Richards, Coordinator is a Legislative Attorney Kevin J. Hickey is a Legislative Attorney Erin H. Ward is a Legislative Attorney Drug Pricing and Pharmaceutical Patenting
Practices https://fas.org/sgp/crs/misc/R46221.pdf 2/11/2020 Congressional Research Service aaditg
Intellectual property (IP) rights in pharmaceuticals --- companies at the expense of the consumer.
That fuels monopolies stifling innovation.
Bryan Mercurio 14, Law Professor at The Chinese University of Hong Kong, “TRIPs, Patents, and Innovation: A Necessary Reappraisal?” https://e15initiative.org/wp-content/uploads/2015/09/E15-Innovation-Mercurio-FINAL.pdf
Identifying the factors that stimulate innovation --- four alternatives to the status quo for discussion.
Err aff – offensive patents are more likely to be used than defensive patents
Gubby 19 (Helen Gubby, Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective, Wiley Online Library, 06 September 2019, https://onlinelibrary.wiley.com/doi/full/10.1111/1758-5899.12730)//ww pbj
Patent system manipulation The patent system --- patent system to some extent, but it is not the entire solution.
Two impacts:
1 Only pharma innovation solves global pandemics that risk extinction
Jeffrey Sachs 14, Professor of Sustainable Development, Health Policy and Management @ Columbia University, Director of the Earth Institute @ Columbia University and Special adviser to the United Nations Secretary-General on the Millennium Development Goals) “Important lessons from Ebola outbreak,” Business World Online, August 17, 2014, http://tinyurl.com/kjgvyro
Ebola is the latest of many recent epidemics --- between humanity and disease-causing agents.
2 Pharma is key to biotech
Garth JS Cooper 6, independent medical scientist at the University of Auckland, “Fates Intertwined,” March 2006, https://library.wur.nl/WebQuery/file/cogem/cogem_t4505194e_001.pdf
Biotechnology and pharmaceuticals are --- the world of human therapeutics will flourish.
Biotech collapse wrecks the economy
Carlson 16,
Robert Carlson is the managing Director at Bioeconomy Capital, “Estimating the biotech sector's contribution to the US economy”, Nature Biotechnology 34, 247–255 (2016), http://www.nature.com/nbt/journal/v34/n3/full/nbt.3491.html?WT.feed_name=subjects_businessandfoxtrotcallback=true#author-information
Biotech is now a major contributor --- Simply put, we should measure everything better.
Economic decline causes global war---the current confluence of tech disruption, nationalism, polarization, and declining multilat make escalation likely
Liu 18 – Dr. Qian Liu, PhD in Economics from Uppsala University, Former Visiting Researcher at the University of California, Berkeley, Managing Director for Greater China at The Economist Group, Guest Lecturer at New York University, Tsinghua University, the Chinese Academy of Social Sciences and Fudan University, “The Next Economic Crisis Could Cause A Global Conflict. Here's Why”, World Economic Forum, 11-13, https://www.weforum.org/agenda/2018/11/the-next-economic-crisis-could-cause-a-global-conflict-heres-why
The next economic crisis is closer --- may well be global conflagration.
Solvency
Plan: The member nations of the World Trade Organization ought to reduce intellectual property protections for medicines
Feldman, 19
(Robin Feldman, Robin Feldman is professor of law and director of the Institute for Innovation Law at UC Hastings College of the Law in San Francisco and author of “Drugs, Money, and Secret Handshakes” (Cambridge University Press, March 2019). 2-11-2019, accessed on 8-13-2021, STAT, "Drug patent protection: it's time for a 'one-and-done' approach - STAT", https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/)WWPP
I believe that one period of protection --- creating patent walls are just too great.
Decreasing patents doesn’t stifle innovation, but increases it through collaboration between companies – empirics
Laurie Garrett 5/21 Laurie Garrett is a columnist at Foreign Policy, a former senior fellow for global health at the Council on Foreign Relations, and a Pulitzer Prize-winning science. MAY 7, 2021, "Stopping Drug Patents Has Stopped Pandemics Before," Foreign Policy, https://foreignpolicy.com/2021/05/07/stopping-drug-patents-pandemics-coronavirus-hiv-aids///anop
U.S. President Joe Biden’s waiver of patent --- is a start, but that’s all that it is.